Physician profile
Anna Parchman
NPI 1578565321
$17,878.15
in general payments reported to CMS, 2019-2025
58 companies · $1,685 in 2025
The $1,685 reported for 2025 was more than what 94% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,898 · 2020: $2,253 · 2021: $3,189 · 2022: $3,320 · 2023: $3,453 · 2024: $2,080 · 2025: $1,685.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,140 · Travel and Lodging: $77.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,139.70 |
| Travel and Lodging | $77.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,261.21 | 2020-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,905.31 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Allergan, INC. | $1,435.15 | 2019-2022 | |
| Amgen INC. | $1,101.24 | 2019-2025 | Repatha, Otezla, Evenity |
| Pfizer INC. | $897.73 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $791.51 | 2019-2025 | Spravato |
| Glaxosmithkline, LLC. | $715.73 | 2019-2025 | Arexvy, Trelegy Ellipta |
| Otsuka America Pharmaceutical, INC. | $715.59 | 2019-2025 | Rexulti, Abilify Maintena |
| Lilly USA, LLC | $691.05 | 2019-2025 | Mounjaro, Jardiance, Emgality |
| Horizon Therapeutics Plc | $667.25 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $390.70 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $320.23 | 2022-2025 | |
| Antares Pharma, INC. | $317.53 | 2020-2025 | Xyosted, Tlando, Nocdurna |
| Gilead Sciences, INC. | $308.79 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $306.91 | 2020-2023 |
Show all 58 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Parchman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.